Cullgen, founded in 2018, is a biopharmaceutical company that develops new chemical entities (NCEs) designed to treat diseases that lack effective therapeutic approaches. Using its proprietary uSMITE™ platform, the company expands on the drug design paradigm aiming to target proteins that are typically resistant to treatments for selective destruction. Cullgen has produced several highly potent, selective, and bioavailable targeted protein degrader compounds. Cullgen is headquartered in San Diego, California.

Register for Details

For more details on financing and valuation for Cullgen, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Cullgen's ticker symbol?

Cullgen does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Cullgen's stock price?

The stock price for Cullgen will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are Cullgen's major investors?

Sequoia Capital China
MSA Capital
Octagon Capital Advisors
Shenzhen Investment
Sincere Capital
Sirius Holding Group
Voyagers Capital
GNI Group
South China Venture Capital
Highlight Capital
Heights Capital Management
3E Bioventures Capital
Wuxi Capital Group

Cullgen Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
5/8/2023 Series C $35MM raised $XXX.XX $XXX.XX
2/25/2021 Series B $50MM raised $XXX.XX $XXX.XX
4/10/2019 Series A $16MM raised $XXX.XX $XXX.XX
3/10/2018 Series Seed-1 and Seed-2 $15MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Cullgen

Forge green plus iconForge green minus icon

What is Cullgen funding to date?

Cullgen has raised $116MM to date.
Forge green plus iconForge green minus icon

When was Cullgen founded?

Cullgen was founded in 2018.
Forge green plus iconForge green minus icon

Can you invest in Cullgen?

Cullgen is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Cullgen share pre-IPO?

If you own Cullgen pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Cullgen a publicly traded company?

Cullgen is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Cullgen in the Healthcare sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$656.14MM
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$705.25MM
Sector
Last Round Est. Valuation
$1.15B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$1.22B
Sector
Last Round Est. Valuation
$500MM
Updated on: May 10, 2023